Published in Blood Weekly, December 19th, 2002
Baxter initiated the verification study to address the rising public concern over the perceived threat of transmission of WNV through use of plasma-derivatives. The study follows recent reports about increased incidence of WNV in the United States and the transmission of WNV through organ donations and blood transfusions.
These data were presented at a 2-day public workshop hosted by the U.S. Food and Drug Administration Center for Biologics Evaluation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.